[111In]-3BP-227

N/A

Report date: 2025/11/21 17:16:24
NME

Base Information

Drug Name[111In]-3BP-227
Drug Alias Name[111In]-3BP-227[111In]FPI-2059[111In]IPN-01087
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionNeurotensin receptor 1 agonistsRadionuclide imaging enhancers
TargetsNeurotensin receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesFusion Pharmaceuticals Inc3B Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A